[Histonet] . Peloris II Tissue Processor

[Mayer,Toysha N]

Charles,
The Peloris is great!  
The advantages is that it is very user friendly.  You can run two different protocols at the same time, due to the dual retorts.  It conserves reagents, because it calculates based on the number of cassettes you tell it you ran.  It automatically rotates the reagents.  We also had a battery backup in case of emergencies.
Disadvantages are if you have a low to moderate workload, it may be too costly.  It is very large in my opinion, so you need more floor space than other processors.  The maintenance plan is well worth its large price.
The lab I worked at during Hurricane Ike in Houston did not have their instrument on a 'red plug', so our processor stopped in the middle of the run.  Leica got to us within a week.  Any other time they were able to help us within a day or so.
On a scale of 1 to 5, I give the Peloris a 5.





------------------------------

Message: 3
Date: Thu, 27 Apr 2017 08:57:21 -0400
From: Charles Riley <criley at dpspa.com>
To: histonet at lists.utsouthwestern.edu
Subject: [Histonet] Peloris II Tissue Processor
Message-ID:
	<CAAQhB12dGC-KAw5CRaiWgt5ya7zbcifrWcMEfXrM=hQw4QGLcg at mail.gmail.com>
Content-Type: text/plain; charset=UTF-8

Does anyone use the Peloris II processor from Leica. We are looking to purchase and I want some background information

1. What are its advantages?

2. What are the disadvantages?

3. Have you experience any technical issue/downtime and how quickly did Leica respond to fix the problem?

4. On a scale of 1 to 5 with 5 being the best how would you compare it to other processors you have used before?

Any help would greatly be appreciated
-- 

Charles Riley HT, HTL(ASCP)CM

Histopathology Coordinator/ Mohs


------------------------------

Subject: Digest Footer

_______________________________________________
Histonet mailing list
Histonet at lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

------------------------------

End of Histonet Digest, Vol 161, Issue 26
*****************************************
The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.